Overview

Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment

Status:
Recruiting

Trial end date:
2023-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare how well two different antibiotics, doxycycline (DOXY) and trimethoprim/sulfamethoxazole (TMP/SMX), work at curing uncomplicated skin and soft tissue infection (uSSTI) such as 1.Boils (pus in the skin, also known as abscesses and furuncles) or 2. Infections that appear only on the skin surface (called cellulitis and erysipelas) that have pus.

Phase:

Phase 2

Details

Lead Sponsor:

Los Angeles Biomedical Research Institute
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Collaborators:

National Institute of Allergy and Infectious Diseases (NIAID)
University of California, Los Angeles
Washington University School of Medicine

Treatments:

Doxycycline
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination